CS
REPL icon

Candriam SCA’s Replimune Group REPL Stock Holding History

Candriam SCA’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-394,027
Closed -$3.01M – 715
2026
Q1 		$3.01M Buy
+394,027
New +$3.01M 0.02% 457
2025
Q3 		– Sell
-171,527
Closed -$1.59M – 696
2025
Q2 		$1.59M Buy
+171,527
New +$1.5M 0.01% 532
2023
Q4 		– Sell
-612,193
Closed -$10.5M – 721
2023
Q3 		$10.5M Hold
612,193
– – 0.07% 227
2023
Q2 		$14.2M Sell
612,193
-50,729
-8% -$991K 0.1% 205
2023
Q1 		$10.8M Hold
662,922
– – 0.07% 250
2022
Q4 		$18M Buy
662,922
+53,350
+9% +$1.11M 0.12% 184
2022
Q3 		$10.5M Buy
609,572
+117,068
+24% +$2.23M 0.07% 259
2022
Q2 		$8.61M Hold
492,504
– – 0.07% 244
2022
Q1 		$8.36M Sell
492,504
-27,008
-5% -$510K 0.06% 279
2021
Q4 		$14.1M Sell
519,512
-2,629
-0.5% -$78.6K 0.09% 219
2021
Q3 		$15.5M Buy
522,141
+36,153
+7% +$1.17M 0.11% 209
2021
Q2 		$18.7M Buy
485,988
+323,828
+200% +$11.1M 0.13% 188
2021
Q1 		$5.94M Buy
162,160
+6
+0% +$225 0.05% 344
2020
Q4 		$6.19M Buy
+162,154
New +$6.76M 0.05% 353

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Candriam SCA's REPL Position: Q2 2026 in Review

Candriam SCA sold out of Replimune Group (REPL) in Q2 2026, closing a stake of 394,027 shares — an estimated $3.01M sold.

Candriam SCA first reported a position in REPL in Q4 2020 and held it in 14 quarters. The position peaked at $18.7M in Q2 2021. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Candriam SCA reported no remaining Replimune Group position as of Q2 2026 after selling out during the quarter.
  • Candriam SCA sold 394,027 Replimune Group shares in Q2 2026, an estimated $3.01M.
  • Candriam SCA first reported a position in Replimune Group in Q4 2020 and held it in 14 quarters.
  • Candriam SCA's Replimune Group position peaked at $18.7M in Q2 2021.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.